Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
82%
Rhesus Macaque
69%
Female Reproductive Tract
66%
Virus
54%
AIDS/HIV
52%
Mucosal Tissues
48%
Mucosal Barrier
33%
Virion
33%
Simian Immunodeficiency Virus
28%
Tissue Sampling
28%
HIV Transmission
23%
Macaque
23%
Sexually Transmitted Infections
21%
Epithelium
21%
Effector Function
20%
Viral Challenge
20%
Squamous Epithelium
19%
Vaginal Tissue
19%
Progestin
19%
HIV Infection
18%
Columnar Epithelium
17%
Immune Cells
17%
Labeled Antibody
17%
COVID-19
17%
Virus Infection
17%
Columnar
17%
Fc Receptor
17%
Nonhuman Primate
17%
Stratum Corneum
17%
HIV Entry
16%
Virus Transmission
16%
Fluorescently Labeled
15%
Foreskin
14%
Fluorophore-conjugated Antibodies
14%
Zonula occludens-1 (ZO-1)
14%
MRNA Expression
14%
Intrauterine Device
14%
Device Use
14%
Dimeric IgA
14%
Topical Interferon
14%
Chemokines
14%
SARS-CoV-2 Neutralizing Antibody
14%
South African
14%
Progesterone
14%
Sexual Transmission
14%
Cell Biology
14%
In Vivo Probe
14%
SARS-CoV-2 Infection
14%
MUC16
14%
Enhanced Transmission
14%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus
99%
Virus
70%
Rhesus Monkey
69%
Mucosal Tissue
50%
Target Cell
38%
Virion
35%
Simian Immunodeficiency Virus
30%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Squamous Epithelium
26%
Viral Entry
25%
Viral Disease
24%
Macaca
22%
Positron Emission Tomography
20%
Columnar Epithelium
20%
Immunocompetent Cell
19%
Stratum Corneum
17%
COVID-19
17%
Fc Receptor
16%
Human Immunodeficiency Virus Infection
15%
Immunoglobulin A
15%
Neutralizing Antibody
15%
Explant
15%
Binding Affinity
15%
Human Immunoglobulin
15%
Monoclonal Antibody
14%
Interferon Type I
14%
Epitope
14%
Virus Transmission
14%
Antibody Conjugate
14%
Cutaneous T Cell Attracting Chemokine
14%
Enhancer Region
14%
Cell Interaction
14%
Gene Sequence
14%
MUC16
14%
Phagocytosis
14%
Cell Phagocytosis
14%
Immunoglobulin G1
14%
Positron Emission Tomography-Computed Tomography
14%
Transcytosis
14%
Blood Plasma
13%
Mucosa
12%
T Cell
11%
Therapeutic Antibodies
10%
T-Helper Cell
10%
HIV Vaccine
9%
Macrophage
9%
Lymph Node
9%
Vagina Mucosa
8%
Infectious Agent
8%